Related references
Note: Only part of the references are listed.High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming
Guangan Hu et al.
NATURE COMMUNICATIONS (2021)
CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner
Jun Ni et al.
CANCER BIOLOGY & MEDICINE (2021)
TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
Shuier Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
A Cdh1-FoxM1-Apc axis controls muscle development and regeneration
Zhe Chen et al.
CELL DEATH & DISEASE (2020)
Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway
Runze Shang et al.
MOLECULAR ONCOLOGY (2020)
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
Yan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer
Susana Ros et al.
CANCER CELL (2020)
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
Monique B. Nilsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
FAM188B Expression Is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer
Young Eun Choi et al.
BIOMEDICINES (2020)
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations
Puyu Shi et al.
TRANSLATIONAL ONCOLOGY (2019)
c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma
Tobias Luebke et al.
CELL DEATH & DISEASE (2019)
Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation
Wen-die Wang et al.
ACTA PHARMACOLOGICA SINICA (2019)
Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton
Laura R. Hardy et al.
ONCOGENE (2019)
FoxM1: Repurposing an oncogene as a biomarker
Deeptashree Nandi et al.
SEMINARS IN CANCER BIOLOGY (2018)
Members of FOX family could be drug targets of cancers
Jinhua Wang et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia
Bei Jin et al.
CLINICAL CANCER RESEARCH (2017)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells
Dejie Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma
Bin Zhang et al.
JOURNAL OF PATHOLOGY (2017)
Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation
Puyu Shi et al.
CLINICAL CANCER RESEARCH (2017)
USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein
Xin-Yan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
F-box protein FBXL2 inhibits gastric cancer proliferation by ubiquitin-mediated degradation of forkhead box M1
Liang-qing Li et al.
FEBS LETTERS (2016)
FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma
Shixiong Lei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment
M. Kongsema et al.
ONCOGENESIS (2016)
FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs
Francesca Consolaro et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma
Zhen Ning et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
Xiaoxiao Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor-Targeted Therapy
Clare McCourt et al.
CLINICAL CANCER RESEARCH (2012)
FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
Trever G. Bivona et al.
NATURE (2011)
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Nagaratna S. Hegde et al.
NATURE CHEMISTRY (2011)
Viral FLIP enhances Wnt signaling downstream of stabilized β-catenin, leading to control of cell growth
S Nakagiri et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cellular FLIP inhibits β-catenin ubiquitylation and enhances Wnt signaling
M Naito et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Share Paper
